A global effort led by Monash University has successfully changed the name of Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome.
The term ‘bikini medicine’ originally highlighted the narrow reproductive focus of women’s health research, but has since broadened into a much-needed campaign for equitable inclusion of women across all aspects of health care. Continued use of this patronising pejorative term may paradoxically diminish rather than augment the overall push for better women’s health. So it’s time to abandon the bikini and in the 21st century seek sex- and gender-specific medicine for the whole person.
Laura Purcell shares a lived experience perspective demonstrating how cycle-aware clinical care transformed premenstrual dysphoric disorder (PMDD) management, reinforcing the need for broader awareness, informed diagnosis and tailored support.
February 2026 marks the twentieth anniversary of the overturning of the Harradine Amendment by the Federal Parliament in 2006. Thanks to the efforts of many people across the country, this parliamentary action opened the way for a cascade of reforms in abortion care for Australian women.
Researchers at the Frazer Institute, UQ, have developed an antibody that targets triple negative breast cancer — as well as other types of cancers — by helping natural killer cells to ‘see’ and kill cancer with fewer roadblocks.
A legacy of exclusion means Australia’s medical system is fundamentally skewed, as it was built for and tested on men
Around one in eight Australian women live with PMOS. Clearer diagnosis and multidisciplinary care are key to supporting their reproductive, metabolic and psychological health across the lifespan.
As prescriptions of GLP-1 receptor agonists for women increase, so too do the number of unexpected pregnancies, prompting calls for clearer prescribing guidelines.
Despite existing guidelines and codes of conduct, many practitioners are failing to refer patients for abortion in a professional manner.
